DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Slamon D, Neven P, Chia S. et al.
Overall survival results of the Phase III MONALEESA-3 trial of postmenopausal patients with hormone receptor-positive human-epidermal growth factor-2-negative advanced breast cancer treated with fulvestrant plus/minus ribociclib.
Ann Oncol 2019;
30 (Suppl. 05) v851-v934
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.